Dybly AG
Pharmaceutical products for patients affected by the build-up of atherosclerotic plaques
Dybly was founded in December 2006 under the name Circomed and has recieved seed funding from ErfindungsVerwertungs AG and a number of private investors from the Basel area.
In 2011, Dybly secured ongoing funding of the project in a newly formed joint venture.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
No news
No milestones
No Jobs
No videos and documents
No Awards
Dybly AG
Pharmaceutical products for patients affected by the build-up of atherosclerotic plaques
Website:
www.dybly.com
Headquarter:
Basel
Foundation Date:
December 2006
Technology:
- Biotech
Sectors:
- Biotech